Slagle Financial, LLC

Position in LLY — ELI LILLY & Co

CIK 1984918 Edwardsville, IL

Position in LLY

as of Jun 30, 2026 · filed Jul 29, 2026 Compact

Position Value

$495,364

+$111,820 QoQ

Shares Held

413

-1.0% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.19%

of 13F equity value

Holder Rank

#3,764

of 4,605 holders

Holding Since

Jun 2023

13 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Slagle Financial, LLC holds $9,819,740 across 7 Drug Manufacturers - General names. LLY ranks #4 (5.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JNJ	Johnson & Johnson	16,066	$4,080,282
2	AMGN	Amgen Inc	9,098	$3,294,567
3	ABBV	AbbVie Inc.	5,092	$1,281,350
4	LLY	ELI LILLY & Co This page	413	$495,364
5	MRK	Merck & Co., Inc.	1,761	$226,288
6	PFE	Pfizer Inc	9,185	$221,174
7	GILD	Gilead Sciences, Inc.	1,747	$220,715

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$495,364	413	-1.0%	Shares	Sole	2026-07-29
2026-03-31	$383,544	417	-23.5%	Shares	Sole	2026-05-01
2025-12-31	$585,700	545	+39.4%	Shares	Sole	2026-01-26
2025-09-30	$298,333	391	+1.0%	Shares	Sole	2025-11-06
2025-06-30	$301,678	387	+1.6%	Shares	Sole	2025-08-11
2025-03-31	$314,671	381	0.0%	Shares	Sole	2025-04-30
2024-12-31	$294,132	381	+1.1%	Shares	Sole	2025-02-12
2024-09-30	$333,999	377	+2.4%	Shares	Sole	2024-10-31
2024-06-30	$333,179	368	+1.4%	Shares	Sole	2024-07-24
2024-03-31	$282,399	363	-59.2%	Shares	Sole	2024-05-16
2023-12-31	$518,798	890	+100.0%	Shares	Sole	2024-03-05
2023-09-30	$239,022	445	-10.5%	Shares	Sole	2023-11-14
2023-06-30	$233,083	497	—	Shares	Sole	2023-08-14
No filing history on record for this holder in this stock.